Thursday, August 03, 2023 6:38:21 AM
Although CGM is important to diabetes care the thing that separates ALRTF from all others is the value added feature (patented, internationally protected) Predictive A1C. Are we too focused on CGM and losing sight of the real prize?
Recent ALRTF News
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/09/2026 04:57:15 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/05/2026 06:15:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/30/2025 06:49:39 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/30/2025 06:38:55 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/07/2025 09:10:05 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 06/26/2025 05:31:37 PM
- Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend] • Edgar (US Regulatory) • 05/02/2025 05:45:54 PM
- Form NT 20-F - Notification of inability to timely file Form 20-F • Edgar (US Regulatory) • 05/01/2025 05:48:37 PM
